Failed IVF 3 Times? Learn The Best Thing To Do

If you’ve experienced three failed IVF embryo transfers, it’s natural to wonder whether something is wrong.

Perhaps you’ve transferred good-quality embryos without achieving a pregnancy. Maybe your embryos were tested and reported as chromosomally normal, yet the treatment still failed. You may now be questioning whether your uterus, endometrial lining or immune system is preventing implantation.

One question often follows: if three embryo transfers have failed, surely repeating the same treatment a fourth or fifth time will fail too?

Not necessarily.

A 2024 study published in Human Reproduction, titled Does recurrent implantation failure exist? Prevalence and outcomes of five consecutive euploid blastocyst transfers in 123,987 patients, investigated what happened when patients continued transferring embryos reported as chromosomally normal after three unsuccessful transfers.

The findings offer an important message for patients experiencing repeated IVF failure: three unsuccessful transfers do not automatically mean that future transfers will fail, or that an unproven fertility treatment add-on is needed.

At Pyramedicine, we believe patients deserve clear, evidence-informed explanations of fertility research so they can discuss their options with their treating specialists and make informed decisions.

What did the 2024 study find?

Gill and colleagues analysed data from an international, multicentre study published in Human Reproduction in 2024.

The researchers examined outcomes following repeated transfers of euploid blastocysts — embryos reported as having the expected number of chromosomes — after previous transfers had failed.

The headline findings were striking.

The distinction between these figures matters. The 98.1% cumulative live birth estimate came from a combined analysis incorporating earlier results from a specific clinic and subsequent transfers. It should not be interpreted as a guarantee for every patient, or as the outcome of all 123,987 patients in the study.

The headline population of 123,987 refers to patients who underwent egg retrieval across participating centres. Only a small, selected group met the study’s criteria for undergoing further euploid embryo transfers after three unsuccessful attempts.

Nevertheless, the results challenge the assumption that repeated failure necessarily means another transfer has little chance of success.

Study reference: Gill P, et al. Does recurrent implantation failure exist? Prevalence and outcomes of five consecutive euploid blastocyst transfers in 123 987 patients. Human Reproduction. 2024;39(5):974–980. Read the original research paper.

If three good embryos failed, why could the fourth or fifth succeed?

This is the central question.

If an embryo looks good and has been reported as euploid, it is understandable to assume that it should implant. When several transfers fail, it can feel as though the uterus must be the problem.

However, embryo implantation and pregnancy development are complex biological processes.

A euploid result is reassuring, but it does not establish that an embryo is capable of producing a live birth. Current preimplantation genetic testing for aneuploidy (PGT-A) assesses chromosome copy number in sampled cells. It cannot identify every genetic, developmental or biological factor that may affect an embryo’s potential.

Even embryos that look similar under a microscope and receive the same PGT-A result can have different developmental potential.

This means that several unsuccessful transfers can occur without proving that the uterus or immune system is responsible.

1. Embryos reported as euploid are not guaranteed to produce a baby

PGT-A can identify many chromosome-number abnormalities, but it is not a comprehensive test of every aspect of embryo health.

It does not guarantee that an embryo will implant, develop normally or result in a live birth. Its findings also need to be interpreted in the context of the biopsy, testing method and clinical circumstances.

A euploid embryo is therefore not the same as a guaranteed viable embryo.

2. Each embryo has its own developmental potential

Embryos can differ in ways that are not fully captured by morphology or chromosome testing.

One embryo may fail to implant, while another embryo from the same IVF cycle may lead to a pregnancy. This can happen even when both embryos were considered suitable for transfer.

Repeated failure may reflect the biological limitations of individual embryos, but that explanation should not be assumed in every case.

3. Probability does not work like a countdown

Three unsuccessful attempts do not automatically make a fourth attempt less likely to succeed.

To illustrate, if a hypothetical embryo transfer had a 40% chance of live birth and each attempt had an independent, unchanged probability, the chance would remain 40% on the next attempt. Previous failures would not mathematically reduce that probability simply because they had occurred.

Real IVF outcomes are more complicated than this example: success probabilities differ between patients, embryos and treatment cycles, and previous outcomes may provide information about individual circumstances.

The important lesson is that three failures do not, by themselves, prove that the next transfer is destined to fail.

Does recurrent implantation failure actually exist?

Recurrent implantation failure (RIF) is a term used when repeated embryo transfers fail to result in a positive pregnancy test or implantation often enough to justify considering further assessment.

It is a genuine clinical concern, but there is no single number of failed transfers that automatically proves a particular underlying diagnosis.

The European Society of Human Reproduction and Embryology (ESHRE) published good-practice recommendations in 2023 emphasising an individualised approach. Rather than defining RIF solely by a fixed number of failed transfers, the recommendations consider the expected cumulative chance of implantation for the individual patient.

ESHRE suggested that further investigations may be considered when the cumulative predicted chance of implantation has exceeded 60% without a successful implantation.

This approach recognises that two patients with the same number of unsuccessful transfers may have different clinical circumstances and different reasons to investigate further.

Repeated failure deserves attention and compassionate care. But a label should not automatically lead to a long list of tests or treatments without a clear rationale.

Read ESHRE’s recommendations on recurrent implantation failure.

Does repeated IVF failure mean something is wrong with the uterus?

Not necessarily.

The uterus and endometrium — the lining of the uterus — are important for implantation, and certain uterine or endometrial conditions can affect fertility treatment outcomes.

Depending on the clinical history, a specialist may consider whether there are issues such as:

• Uterine cavity abnormalities, including certain polyps, fibroids or adhesions.
• Hydrosalpinx, where fluid-filled fallopian tubes may affect IVF outcomes.
• Endometrial abnormalities or other clinically suspected conditions.
• Difficulties with embryo transfer or the treatment protocol.
• Other relevant medical or reproductive factors.

An appropriate assessment depends on symptoms, medical history, previous investigations and the details of the failed cycles.

However, repeated failed transfers alone do not establish that the uterus is the cause. Equally, the study does not prove that uterine or endometrial factors are unimportant.

If three or more transfers have failed, it is reasonable to ask your fertility specialist whether the existing investigations adequately assess the uterine cavity and whether any further targeted evaluation is justified.

The aim should be to identify a problem that can meaningfully change management, rather than to pursue every available test.

Should you have immune testing after repeated failed IVF?

Some clinics offer immune investigations or treatments to patients experiencing recurrent implantation failure. These may include tests for selected immune markers and treatments intended to modify immune activity.

However, the evidence does not support assuming that an immune problem is responsible for every repeated failure.

ESHRE’s recommendations highlight that many proposed investigations and interventions for RIF have limited or insufficient evidence of benefit. Tests and treatments should be considered in light of a plausible clinical indication, evidence of effectiveness and potential risks.

This does not mean that immune-related conditions can never affect reproductive outcomes. It means that immune dysfunction should not be diagnosed solely because several embryo transfers have failed.

What about steroids, intralipids and intravenous immunoglobulin?

These interventions are sometimes discussed in fertility care, but they are not universally recommended for unexplained repeated implantation failure.

Their potential benefits, risks and evidence base differ. Some may expose patients to costs and medical risks without reliable evidence that they improve the chance of live birth in their particular circumstances.

Before agreeing to an immune-related treatment, ask your specialist:

• What specific condition is this treatment intended to address?
• Is there a validated test supporting that diagnosis?
• What evidence shows that the treatment improves live birth rates in patients like me?
• What are the risks and costs?
• What would be the alternative if I chose not to have it?

The decision should be individualised, and prescribed medication should never be stopped or changed without medical advice.

Are blood thinners or other IVF add-ons necessary after three failed transfers?

Not automatically.

Blood thinners such as heparin or aspirin may have specific indications in some patients, but repeated IVF failure alone does not establish a need for them.

Similarly, procedures and tests marketed as fertility add-ons should be evaluated individually. The fact that a treatment is available does not mean that it improves live birth rates.

ESHRE’s recommendations on recurrent implantation failure advise against routinely offering several interventions that lack sufficient evidence of benefit. The organisation has also published separate evidence-based recommendations on add-ons in reproductive medicine.

Explore ESHRE’s guidance on fertility add-ons.

For patients, the practical message is simple: before paying for an additional test or treatment, understand the medical rationale and whether good-quality evidence demonstrates a meaningful benefit.

Does the study prove that failed IVF is almost always an embryo problem?

No — and this distinction is important.

The study provides evidence that some patients can achieve a live birth after several unsuccessful euploid embryo transfers, with success rates after the fourth and fifth transfers remaining substantial in the selected group studied.

It does not prove that 98% of all failed IVF cycles are caused by embryos, that uterine or immune factors are irrelevant, or that additional investigation is never needed.

The 98.1% cumulative live birth estimate applies to the study’s combined analysis, not to every patient undergoing IVF or every patient with recurrent implantation failure.

The study also cannot establish the cause of each previous unsuccessful transfer. It demonstrates that repeated failure does not necessarily prevent subsequent success.

The most appropriate conclusion is that patients should receive individualised assessment, avoid assuming a diagnosis without evidence, and be counselled about the realistic benefits and limitations of further treatment.

What should you do after three failed IVF transfers?

If you’ve experienced three unsuccessful embryo transfers, it is understandable to feel frustrated, worried or exhausted. A structured review can help you decide what to do next without automatically committing to another expensive intervention.

Consider discussing the following with your fertility specialist.

1. Review the previous cycles

Ask whether the embryos were fresh or frozen, whether PGT-A was performed, how the embryos developed, what happened after each transfer and whether any patterns have emerged.

2. Check whether the uterine assessment is appropriate

Review the results of previous ultrasound scans and other investigations. Ask whether further assessment is indicated by your medical history or findings.

3. Revisit the embryo information

Ask what the embryo grading and any genetic testing can — and cannot — tell you. Discuss the number of embryos remaining and how the clinic estimates your chance of success.

4. Review the treatment protocol

Your clinician may review endometrial preparation, medication timing, progesterone exposure and the embryo-transfer procedure where relevant. Changes should be based on the clinical details rather than made automatically.

5. Ask for evidence before pursuing add-ons

For any proposed immune test, blood thinner, infusion or other add-on, ask whether it is recommended for your specific circumstances and whether it has been shown to improve live birth rates.

6. Discuss the next transfer realistically

Ask for an individualised estimate of success based on your age, diagnosis, embryo characteristics, previous treatment and remaining options.

You should feel able to ask questions, seek a second opinion and take time to make a decision.

What this means for patients considering IVF in Egypt

Patients exploring fertility treatment abroad often have to weigh clinical options alongside cost, travel and the emotional impact of previous unsuccessful cycles.

At Pyramedicine, we believe that fertility decisions should be informed by evidence, realistic expectations and an individual assessment.

If you are considering IVF in Egypt after previous unsuccessful transfers, it is worth discussing your medical history, existing investigations, embryo information and proposed treatment plan with the treating fertility specialist before travelling.

Questions to clarify include:

• Can my previous IVF records and investigations be reviewed before I travel?
• What additional assessment, if any, is clinically justified?
• What treatment protocol is being proposed, and why?
• What are the estimated costs, including medication, laboratory treatment and embryo transfer?
• Which additional treatments are optional, and what evidence supports them?
• How will follow-up be arranged if I return home after treatment?

Pyramedicine can help you enquire about fertility treatment options in Egypt and understand the practical arrangements involved. Medical suitability and treatment decisions should remain with the qualified fertility team responsible for your care.

Frequently asked questions about repeated IVF failure

Can IVF work after three failed embryo transfers?

Yes. A failed transfer does not mean that the next transfer cannot succeed. Gill and colleagues’ 2024 study reported substantial live birth rates after fourth and fifth euploid blastocyst transfers in a selected group of patients. Your own chances depend on your individual circumstances.

If three euploid embryos failed, does that mean I have recurrent implantation failure?

Repeated unsuccessful transfers may warrant an assessment for recurrent implantation failure, but the number of failures alone does not identify the cause. ESHRE recommends considering the expected cumulative probability of implantation and the patient’s individual clinical history.

Does a euploid embryo guarantee pregnancy?

No. PGT-A assesses chromosome copy number in sampled cells. A euploid result does not guarantee implantation, ongoing pregnancy or live birth.

Should I have immune testing after three failed IVF attempts?

Not automatically. Immune testing should be considered only where there is a clear clinical rationale and the results could meaningfully affect management. Many proposed investigations and immune treatments for unexplained recurrent implantation failure lack sufficient evidence for routine use.

Should I take aspirin or heparin after repeated failed IVF?

Not solely because several transfers have failed. These medicines have specific indications and potential risks. Discuss any proposed treatment with your fertility specialist and do not start or stop prescribed medication independently.

Is the fourth embryo transfer more successful than the first?

The study reported a live birth rate of approximately 40% after the fourth transfer and approximately 53% after the fifth in its selected study group. These figures do not prove that later transfers are more successful than earlier ones; they show that meaningful success remained possible after previous failures.

What did the study’s 98% figure mean?

The authors reported a cumulative live birth rate of 98.1% in a combined analysis of five euploid blastocyst transfers, incorporating earlier data from a specific clinic and subsequent outcomes. It is not a universal success rate for IVF or a guarantee that everyone will achieve a live birth after five transfers.

Should I repeat the same IVF treatment after three failures?

That depends on your medical history, previous treatment, embryo information and investigations. Sometimes another transfer using a similar approach may be reasonable; in other circumstances, a targeted change or further assessment may be appropriate. Discuss the evidence and alternatives with your specialist.

The key takeaway: Three failed transfers do not mean hope is lost

The 2024 Gill et al. study challenges the assumption that repeated embryo-transfer failure necessarily predicts failure in every subsequent attempt.

Some patients achieved a live birth after a fourth or fifth transfer of a euploid blastocyst, demonstrating that another attempt can still have a meaningful chance of success.

But the findings should not be interpreted as proof that all repeated IVF failures are embryo-related or that further investigations are never needed.

The best next step is a thoughtful review of your individual circumstances, with investigations and treatments guided by evidence rather than fear or the pressure to purchase additional interventions.

At Pyramedicine, we encourage patients to ask questions, understand their options and make informed decisions about fertility treatment. If you’re exploring IVF in Egypt after previous unsuccessful cycles, contact Pyramedicine to enquire about your options and the next steps.